FDA Inspection
Nathan Segall, MD, CPINathan Segall, MD, CPI – FDA Inspection, Apr 26, 2018
Record Details
This FDA Inspection record concerns Nathan Segall, MD, CPI, with an inspection on April 26, 2018, issued by the Center for Tobacco Products, covering tobacco.
- People
- Karen M. Cooper (Company Rep)
- Michelle M. Noe Varga (Issuing Officer)
View Company Profile
ID · 0cfa43b6-43c4-4eb9-b10d-14b695af79bd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1054003
- FDA center
- Tobacco Products
- Project area
- Bioresearch Monitoring
Other FDA inspections of Nathan Segall, MD, CPI
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 13, 2021 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Nathan Segall, MD, CPI
- FDA Inspection 1149848 - 2021-08-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.